JUPITER NEUROSCIENCES, INC. Deferred Compensation Liability, Current
JUPITER NEUROSCIENCES, INC. (JUNS) had Deferred Compensation Liability, Current of $1.41 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Deferred Compensation Liability, Current $1.41M.
- 2026-03-31: Deferred Compensation Liability, Current $1.42M.
- 2025-12-31: Deferred Compensation Liability, Current $1.40M.
- 2025-09-30: Deferred Compensation Liability, Current $1.85M.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2026-06-30 | $1.41M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.42M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.40M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.85M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.86M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $1.41M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.42M 10-K · filed 2026-04-01 |
| 2024-09-30 | $2.00M 10-Q · filed 2024-12-23 |
| 2023-12-31 | $1.56M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |